CN102218024B - 一种祛痘的组合物及其在化妆品中的应用 - Google Patents
一种祛痘的组合物及其在化妆品中的应用 Download PDFInfo
- Publication number
- CN102218024B CN102218024B CN 201010149335 CN201010149335A CN102218024B CN 102218024 B CN102218024 B CN 102218024B CN 201010149335 CN201010149335 CN 201010149335 CN 201010149335 A CN201010149335 A CN 201010149335A CN 102218024 B CN102218024 B CN 102218024B
- Authority
- CN
- China
- Prior art keywords
- acne
- kilogram
- kilograms
- extract
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 20
- 239000002537 cosmetic Substances 0.000 title claims abstract description 10
- 239000000284 extract Substances 0.000 claims abstract description 37
- 241000746375 Andrographis Species 0.000 claims abstract description 20
- 235000019136 lipoic acid Nutrition 0.000 claims abstract description 13
- 229960002663 thioctic acid Drugs 0.000 claims abstract description 13
- 206010000496 acne Diseases 0.000 claims description 29
- 208000002874 Acne Vulgaris Diseases 0.000 claims description 27
- AGBQKNBQESQNJD-SSDOTTSWSA-N (R)-lipoic acid Chemical compound OC(=O)CCCC[C@@H]1CCSS1 AGBQKNBQESQNJD-SSDOTTSWSA-N 0.000 claims description 15
- AGBQKNBQESQNJD-UHFFFAOYSA-N alpha-Lipoic acid Natural products OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 claims description 13
- 229930183118 Tanshinone Natural products 0.000 claims description 11
- AIGAZQPHXLWMOJ-UHFFFAOYSA-N Tanshinone I Chemical compound C1=CC2=C(C)C=CC=C2C(C(=O)C2=O)=C1C1=C2C(C)=CO1 AIGAZQPHXLWMOJ-UHFFFAOYSA-N 0.000 claims description 10
- 239000000654 additive Substances 0.000 claims description 2
- 230000000996 additive effect Effects 0.000 claims description 2
- 239000000969 carrier Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 10
- 239000009123 dan-shen root extract Substances 0.000 abstract 1
- AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical compound [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
- 238000003756 stirring Methods 0.000 description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 210000003491 skin Anatomy 0.000 description 9
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 230000003255 anti-acne Effects 0.000 description 6
- 230000002421 anti-septic effect Effects 0.000 description 6
- 210000003780 hair follicle Anatomy 0.000 description 6
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 5
- 229920002125 Sokalan® Polymers 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 229960001631 carbomer Drugs 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 235000014593 oils and fats Nutrition 0.000 description 5
- 239000003643 water by type Substances 0.000 description 5
- 241000283973 Oryctolagus cuniculus Species 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- 230000003780 keratinization Effects 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 3
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 3
- 241000186427 Cutibacterium acnes Species 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 240000007711 Peperomia pellucida Species 0.000 description 3
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 3
- 229930003427 Vitamin E Natural products 0.000 description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000001815 facial effect Effects 0.000 description 3
- 230000001408 fungistatic effect Effects 0.000 description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 229940075529 glyceryl stearate Drugs 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 239000010977 jade Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 3
- 229920000570 polyether Polymers 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 229940055019 propionibacterium acne Drugs 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 235000019155 vitamin A Nutrition 0.000 description 3
- 239000011719 vitamin A Substances 0.000 description 3
- 235000019165 vitamin E Nutrition 0.000 description 3
- 229940046009 vitamin E Drugs 0.000 description 3
- 239000011709 vitamin E Substances 0.000 description 3
- 229940045997 vitamin a Drugs 0.000 description 3
- 241000228245 Aspergillus niger Species 0.000 description 2
- 244000063299 Bacillus subtilis Species 0.000 description 2
- 235000014469 Bacillus subtilis Nutrition 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- AXISYYRBXTVTFY-UHFFFAOYSA-N Isopropyl tetradecanoate Chemical class CCCCCCCCCCCCCC(=O)OC(C)C AXISYYRBXTVTFY-UHFFFAOYSA-N 0.000 description 2
- 241000228143 Penicillium Species 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- 206010037888 Rash pustular Diseases 0.000 description 2
- 241000295644 Staphylococcaceae Species 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000003098 androgen Substances 0.000 description 2
- 230000002280 anti-androgenic effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000003385 bacteriostatic effect Effects 0.000 description 2
- 239000011280 coal tar Substances 0.000 description 2
- 238000007599 discharging Methods 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 230000001076 estrogenic effect Effects 0.000 description 2
- 230000003325 follicular Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 238000005286 illumination Methods 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 208000029561 pustule Diseases 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- 208000020154 Acnes Diseases 0.000 description 1
- 244000118350 Andrographis paniculata Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010011732 Cyst Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- DNXHEGUUPJUMQT-CBZIJGRNSA-N Estrone Chemical compound OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 DNXHEGUUPJUMQT-CBZIJGRNSA-N 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 206010016936 Folliculitis Diseases 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 101100460844 Mus musculus Nr2f6 gene Proteins 0.000 description 1
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 1
- 240000003864 Ulex europaeus Species 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 239000000051 antiandrogen Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000035606 childbirth Effects 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 230000006020 chronic inflammation Effects 0.000 description 1
- 210000000589 cicatrix Anatomy 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000001054 cortical effect Effects 0.000 description 1
- 239000000490 cosmetic additive Substances 0.000 description 1
- 239000003581 cosmetic carrier Substances 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 239000000745 gonadal hormone Substances 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000007390 skin biopsy Methods 0.000 description 1
- 239000002884 skin cream Substances 0.000 description 1
- 210000003859 smegma Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
一种祛痘的组合物，提供一种含有穿心莲提取物、丹参提取物和硫辛酸的组合物，本组合物组分合理，是一种能产生协同作用，效果显著的安全稳定的皮肤祛痘组合物，以及该组合物在化妆品及皮肤科领域的应用。
Description
技术领域
本发明涉及一种祛痘护肤组合物，具体来说涉及一种含有穿心莲提取物、丹参提取物和硫辛酸的组合物及其在化妆品的应用，属于化妆品领域。
背景技术
痤疮又叫青春痘、粉刺、毛囊炎，是发生于毛囊皮脂腺的一种慢性炎症性疾病，临床上主要表现在面部、胸部及背部出现粉刺、丘疹、脓疱、囊肿和结节，有的可形成瘢痕，严重影响人们的容貌，对正常人的就业、社交和婚育等产生重要影响。目前认为痤疮的发病与雄激素水平、皮脂分泌增加、毛囊导管角化过度、痤疮丙酸杆菌感染有关。
痤疮的形成过程：油光满面，油脂过多→毛孔粗大/堵塞→皮脂腺分泌油脂→角质层增厚，油脂渐往皮层表面隆起→角质层隆起，油脂堵塞毛孔，隆起的顶点氧化变成黑色→细菌在毛孔里和油脂搅和在一起→痤疮丙酸杆菌在缺氧情况下大量繁殖→导致炎症细菌侵入，变成脓疱、结节→整个毛囊变红、发炎→细菌扩散到附近的皮肤组织，变得更大，进而形成痤疮。
丹参提取物具有活血调经、祛瘀生新、镇静安神、凉血消痈、消肿止痛等功能。丹参中活性成分丹参酮有抗菌作用，对痤疮杆菌高度敏感，且是一种缓和的雌激素样物质，起着抗雄性素作用，同时还具有类似氢化可的松的抗炎作用，对革兰阳性细菌抗菌作用强，可明显降低痤疮丙酸杆菌计数，并能抑制急性与亚急性炎症反应，有抗炎作用。尚有温和的雌激素样活性和抗内酸睾丸酮作用，抗雄激素作用和抗皮脂腺分泌作用确切。性激素尤其是雄性激素同痤疮的发生、发展、持续状态有密切的关系。丹参酮避免了通常应用雌激素治疗痤疮，干扰病人体内代谢的缺点，从多方面改善了痤疮的临床症状.适应范围更广。此外，丹参酮具有的活血化瘀功能尚町改善面部的血液循环，促进病变皮肤的新陈代谢。
穿心莲Andrographis paniclata(Burm.f.)Nees的地上部分，又名一见喜、斩蛇剑、印度草等，为爵科植物。味苦、寒，人心、肺、胃大肠经。穿心莲具有清热解毒、凉血消肿之功，对多种感染性疾病有效；穿心莲提取物对金色葡萄球菌、枯草杆菌、大肠杆菌、黑曲霉、青霉都有明显的抑菌效果，其中对大肠杆菌的抑菌效果最强。穿心莲提取物在pH 4～7时保持较强的抑菌效果，当pH＝8时，对供试菌的抑菌活性减弱，pH＝9时，对黑曲霉、青霉的抑菌活性消失，对金色葡萄球菌、枯草杆菌、大肠杆菌仍然有抑制活性。
硫辛酸英文名为thioctic acid或a-lipoic acid，具有脂溶性和水溶性双重特性，是已知天然抗氧化剂中效果最强的一种，被誉为万能氧化剂，其特点为高效、低毒，由于它具有脂溶性水溶性的双重特性，可以快速渗入到皮肤，分散到细胞的所有部分，对皮肤疤痕、色斑有很好的美白作用。
本品组合物主要是通过抑制痤疮杆菌等痤疮致病菌的活性和抗氧化作用，从而达到祛痘祛斑的功效。
发明内容
本发明的目的在于提供一种组分合理，能产生协同作用，效果显著的安全稳定的皮肤祛痘组合物，以及该组合物在化妆品及皮肤科领域的应用。
本发明的技术方案如下：本化妆品按重量计它含有0.001％～20％穿心莲提取物、0.001％～30％丹参提取物和0.001％～10％硫辛酸。优选0.002％～4％穿心莲提取物、0.01％～12％丹参酮提取物和0.005％～3％硫辛酸。
另外，常用化妆品助剂、载体或这些物质的混合物组成了其他部分，使总量达到100％。
本发明化妆品组合物可用作制备防晒霜、防晒露、晒后产品、日霜、晚霜、面膜、润肤露、洗面奶、爽肤粉、眼状、发膜、护发素、精油以及在彩妆产品中，如除臭棒、香料棒、啫喱等，上述的产品由本行业熟知的技术制造。特别适用于制备霜剂、乳剂、凝胶、面膜膏剂。
同时该组合物可以作为祛痘美白化妆品的添加剂。
具体实施方式
本发明将通过实施例来进一步详述。所有的成分除特别指明的以外，均以百分重量表示。
| 组分 | 实施例1 | 实施例2 | 实施例3 | 实施例4 | 实施例5 |
| 丹参提取物 | 0.001 | 0.02 | 12 | 0.02 | 0.05 |
| 穿心莲提取物 | 0.001 | 0.2 | 4 | 0.05 | 0.2 |
| 硫辛酸 | 0.001 | 0.005 | 1 | 0.5 | 0.2 |
| 甘油 | 5.0 | 5.0 | 6.0 | ||
| 琼蜡硬脂醇聚醚 | 4.0 | 4.0 | |||
| 维生素E | 0.5 | 1.0 | |||
| 维生素A | 0.2 | 0.5 | |||
| 肉豆蔻酸异丙酯 | 4.0 | 5.0 | |||
| 橄榄油 | 5.0 | ||||
| 甘油硬脂酸酯 | 4.0 | 4.0 | |||
| 聚山梨醇酯80 | 4.0 | 4.0 | 8.0 | 8.0 | 8.0 |
| 防腐剂 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 |
| 卡波姆 | 0.2 | 0.2 | 1.0 | 0.3 | |
| 三乙醇胺 | 0.2 | 0.2 | 1.0 | 0.3 |
| 聚乙烯醇 | 10.0 | ||||
| 乙醇 | 8.0 | ||||
| 香精 | 0.1 | 0.1 | 0.05 | 0.05 | 0.1 |
| 水 | 77.60 | 70.58 | 68.75 | 85.18 | 65.65 |
| 丙二醇 | 10.0 | 6.0 |
实施例1祛痘乳液
将0.2公斤防腐剂、5公斤甘油、0.2公斤卡波姆、77.60公斤去离子水，搅拌均匀，加热至85摄氏度备用；将0.001公斤丹参提取物、0.001公斤穿心莲提取物、0.001公斤硫辛酸、4公斤甘油硬脂酸酯、4公斤琼蜡硬脂醇聚醚、0.5公斤维生素E、0.2公斤维生素A、4公斤肉豆蔻酸异丙酯、4公斤聚山梨醇酯80，加热至85摄氏度，慢慢加入水相，均质3000转/分钟，冷却至50摄氏度，加入0.1公斤香精，搅拌均匀，35摄氏度出料。
实施例2祛痘霜
将0.2公斤防腐剂、5公斤甘油、0.2公斤卡波姆、70.58公斤去离子水、10公斤聚甲基丙烯酸甘油酯，搅拌均匀，加热至85摄氏度备用；将0.02公斤丹参提取物、0.2公斤穿心莲提取物、0.005公斤硫辛酸、4公斤甘油硬脂酸酯、4公斤琼蜡硬脂醇聚醚、1公斤维生素E、0.5公斤维生素A、5公斤橄榄油、5公斤肉豆蔻酸异丙酯、4公斤聚山梨醇酯80，加热至85摄氏度，慢慢加入水相，均质3000转/分钟，冷却至50摄氏度，加入0.1公斤香精，搅拌均匀，35摄氏度出料。
实施例3祛痘凝胶
将0.2公斤防腐剂、68.75公斤去离子水，加热使溶解，放冷，加入6公斤甘油、1公斤卡波姆、搅拌均匀，备用，将12公斤丹参提取物、4公斤穿心莲提取物、1公斤硫辛酸、8公斤乙醇、10公斤丙二醇、8公斤聚山梨醇酯80、0.1公斤香精，搅拌使溶解，慢慢加入水相，搅拌均匀。
实施例4祛痘化妆水
将0.02公斤丹参提取物、0.05公斤穿心莲提取物、0.5公斤硫辛酸、0.2公斤防腐剂、6公斤丙二醇、8公斤聚山梨醇酯80，加热使溶解，加入051公斤香精，在搅拌下缓缓加入85.18公斤去离子水中，搅拌至均匀透明。
实施例5祛痘面膜
将0.05公斤丹参提取物、0.2公斤穿心莲提取物、0.2公斤硫辛酸、0.2公斤防腐剂、15公斤乙醇、8公斤聚山梨醇酯80、0.1公斤香精，搅拌使溶解，加入0.3公斤卡波姆，搅匀，加入0.3公斤三乙醇胺调节PH至7.0；将65.65公斤去离子水、10公斤聚乙烯醇，加热搅拌使溶解，慢慢加入油相，搅拌均匀
实施例6光照实验稳定性考察
实验方法：将供试品开口放在装有日光灯的光照箱内，在照度为4500lx±500lx的条件下放置30天，于第5天、第10天、第30天取样，以丹参酮为测定指标，考察样品变化情况；结果显示，加硫辛酸组可以提高丹参提取物的稳定性；未加硫辛酸组丹参提取物丹参酮含量下降50％，而加硫辛酸组丹参提取物丹参酮含量下降8％。
实施例7药效研究
1对家兔耳实验性痤疮模型的治疗作用
实验选用健康白色家兔44只，体重2.0-2.5kg，雌雄兼用，雌性未孕。按文献方法，取38只家兔，于每只家兔右耳内侧耳管开口处2*2cm范围，每日涂煤焦油1次，每次0.5ml，连续两周，另6只作为正常对照组。第14天，取2只家兔于涂煤焦油处取皮肤活检，以确定模型是否形成。然后，随机分5组，设空白组、模型对照组和实验组(组分一：丹参提取物；组分二：穿心莲提取物；组分三：丹参酮提取物+穿心莲提取物)三组。按以上实施1处方制备3份乳剂，作为样品，持续3周。同条件饲养。每日除给药外，应肉眼观察局部给药处皮肤的变化，耳厚薄、硬度、粗糙程度、毛囊口有无黑角栓等。末次给药后24小时，取下涂药处皮肤(全层)，10％福尔马林溶液固定后，并按下述标准进行组织学观察、显微照相。参照文献按其表皮增厚及毛囊口扩张程度、角化物质多少将其病理变化分为四级：“0”为无粉刺；“+”为毛囊漏斗部可见少量角化物；“++”为毛囊漏斗部可见中等量角化物质，并向皮脂腺延伸；“+++”为扩张的毛囊内有广泛的角化物质。
对兔耳痤疮模型治疗后的病理学改变
研究表明，本处方对实验性兔耳痤疮模型有较好的治疗作用，有明显减少毛囊角栓，减轻表皮增厚，减少真皮炎细胞浸润；
实施例8祛痘临床研究
组分一：丹参提取物；组分二：穿心莲提取物；组分三：丹参酮提取物+穿心莲提取物。按以上实施1处方制备3份乳剂，作为样品，选择60名15～30岁的作为受试者，采用双盲法每天早晚洗脸后在每位受试者成员的脸部涂用适量制剂。
疗效标准：显效痤疮(包括寻常痤疮和脓胞性痤疮)消退80％以上残留或新生痤疮少于5个，好转痤疮消退70％~80％残留或新生痤疮少于10个无效痤疮消退70％以下残留或新生痤疮多于10个。
Claims (2)
1.一种含有丹参酮提取物和穿心莲提取物的祛痘组合物，其特征在于，所述该组合物按重量计含有0.001％穿心莲提取物、0.001％丹参酮提取物和0.001％硫辛酸，余量为其他可接受的载体。
2.根据权利要求1所述的祛痘组合物，其特征在于，该组合物可作为祛痘化妆品的添加剂。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201010149335 CN102218024B (zh) | 2010-04-19 | 2010-04-19 | 一种祛痘的组合物及其在化妆品中的应用 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201010149335 CN102218024B (zh) | 2010-04-19 | 2010-04-19 | 一种祛痘的组合物及其在化妆品中的应用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102218024A CN102218024A (zh) | 2011-10-19 |
| CN102218024B true CN102218024B (zh) | 2013-01-16 |
Family
ID=44774911
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201010149335 Expired - Fee Related CN102218024B (zh) | 2010-04-19 | 2010-04-19 | 一种祛痘的组合物及其在化妆品中的应用 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102218024B (zh) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103284906B (zh) * | 2013-05-10 | 2015-02-04 | 江琴 | 一种抗菌止痒面膜 |
| CN106389204A (zh) * | 2016-10-23 | 2017-02-15 | 广东轻工职业技术学院 | 一种兼具控油和祛痘功效的植物药组合物及应用 |
| CN109498536A (zh) * | 2018-12-15 | 2019-03-22 | 横琴智库转化医学有限公司 | 一种含中药提取液的化妆品组合物 |
| CN110051729A (zh) * | 2019-03-06 | 2019-07-26 | 深圳市龙岗区横岗红运来电子加工厂 | 一种祛痘组合物及其制备方法 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1189327A (zh) * | 1997-01-27 | 1998-08-05 | 浙江东方巨星珍珠制品有限公司 | 超微珍珠玉容膏及其制备工艺 |
| CN1369485A (zh) * | 2001-12-27 | 2002-09-18 | 广州美晨药业有限公司 | 一种超临界二氧化碳萃取精制丹参酮iia的方法 |
| CN101125850A (zh) * | 2007-08-08 | 2008-02-20 | 暨南大学 | 穿心莲内酯衍生物及其在制药中的应用 |
| CN101590037A (zh) * | 2009-06-29 | 2009-12-02 | 暨南大学 | 一种穿心莲内酯组合物及其用途 |
-
2010
- 2010-04-19 CN CN 201010149335 patent/CN102218024B/zh not_active Expired - Fee Related
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1189327A (zh) * | 1997-01-27 | 1998-08-05 | 浙江东方巨星珍珠制品有限公司 | 超微珍珠玉容膏及其制备工艺 |
| CN1369485A (zh) * | 2001-12-27 | 2002-09-18 | 广州美晨药业有限公司 | 一种超临界二氧化碳萃取精制丹参酮iia的方法 |
| CN101125850A (zh) * | 2007-08-08 | 2008-02-20 | 暨南大学 | 穿心莲内酯衍生物及其在制药中的应用 |
| CN101590037A (zh) * | 2009-06-29 | 2009-12-02 | 暨南大学 | 一种穿心莲内酯组合物及其用途 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102218024A (zh) | 2011-10-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106580797B (zh) | 一种美白祛斑霜及其制备方法 | |
| Chauhan et al. | Creams: a review on classification, preparation methods, evaluation and its applications | |
| CA2444282C (en) | Preparation for hair and/or scalp | |
| CN109498478A (zh) | 一种富勒烯外用组合物 | |
| US20190269738A1 (en) | Camelid compound(s), composition(s) and method(s) | |
| CN102218024B (zh) | 一种祛痘的组合物及其在化妆品中的应用 | |
| JP2007516185A (ja) | 皮膚科用及び／又は化粧料用組成物における酸化防止剤の使用 | |
| CN103494737A (zh) | 一种以姜花作为抗衰老护肤因子的化妆品制剂及制备方法 | |
| JP2005047910A (ja) | 皮脂分泌抑制用組成物 | |
| CN108056931A (zh) | 一种祛痘霜及其制备方法 | |
| JP2006321758A (ja) | 化粧品 | |
| CN101822624B (zh) | 一种含有硫辛酸和丹参提取物的组合物及其在化妆品中的应用 | |
| CN103385838A (zh) | 祛斑美白乳液 | |
| CA2700335A1 (en) | Composition comprising mucilaginous polysaccharides derived from aloe barbadensis combined with liposomes, method for obtaining same and use thereof as a sun protector, an anti-acne agent, an epidermal regenerator and a moisturiser | |
| CN113081933A (zh) | 祛痘组合物及其制备方法与应用 | |
| US9408877B1 (en) | Compositions and process for skin restoration | |
| ITUB20159582A1 (it) | Composizione, per uso topico, utile per la prevenzione di disturbi di tipo infiammatorio e/o infettivo delle mucose. | |
| KR20040056079A (ko) | 여드름 예방 및 치료용 화장료 조성물 | |
| KR100909729B1 (ko) | 남실 추출물을 함유한 여드름 예방 및 개선용 화장료 조성물 | |
| KR20200059659A (ko) | 천연 두피 파우더 | |
| JP2000198717A (ja) | ゴマを使った白髪改善剤 | |
| KR20200013925A (ko) | 천연 아로마 오일의 모발 및 두피 개선효과를 증진시키는 블랜딩 제조방법 | |
| JPH10120561A (ja) | 津液改善用皮膚外用剤 | |
| KR101040011B1 (ko) | 모낭충 살균제 | |
| Cream | Our latest news on skincare, hair, clean beauty & sustainable style. Skincare Products+ Skin Care Techniques Skin Products & Devices |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| DD01 | Delivery of document by public notice |
Addressee: Tong Yuxin Document name: payment instructions |
|
| DD01 | Delivery of document by public notice | ||
| DD01 | Delivery of document by public notice |
Addressee: Tong Yuxin Document name: Notice of Termination of Patent Rights |
|
| DD01 | Delivery of document by public notice | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130116 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |